DOST on Ivermectin: Clinical Trial not Needed


Ivermectin retakes the stage as a possible treatment for COVID-19.

Doctors from Concerned Doctors and Citizens PH (CDC PH) are more than willing to undergo a clinical trial to prove the effectiveness of the wonder drug.

But Fortunator de la Peña, Department of Science and Technology (DOST) Secretary state that clinical analyses are not required for the drug as trials worldwide are ongoing.

Through a Facebook post, de la Peña stated:

“Clinical trial projects will require a minimum of six months and can extend to years. That is how long we have to wait to have results and conclusions.”

The data available at shows almost twenty trials are finished while 40 are still ongoing, focusing on the analyses and formulations for COVID-19 treatment.

Recently, the Food and Drug Administration (FDA) grants one hospital compassionate special permit or CSP to make Ivermectin available for the use intended for COVID-19 patients on April 08.

Like it? Share with your friends!

Lois I.